Ipsen Ltd.
🇬🇧United Kingdom
Clinical Trials
3
Active:3
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
15
EMC:15
Drug Approvals
Salvacyl 11.25 mg powder and solvent for prolonged-release suspension for injection
- Approval Date
- Jul 7, 2025
EMC
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)No trials found
News
No news found